(Q35564813)

8 August 2017

title

Pharmacokinetics of LY163892 in infants and children (English)

1 reference

8 August 2017

1 reference

Nelson JD

1

1 reference

8 August 2017

Shelton S

series ordinal

2

1 reference

8 August 2017

Kusmiesz H

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

published in

1 reference

8 August 2017

volume

32

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

1738-1739

1 reference

Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175962

In vitro activities of LY163892, cefaclor, and cefuroxime

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175962

In vitro susceptibilities of common pediatric pathogens to LY163892.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175962

Pharmacokinetics of cefaclor in infants and children

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175962

12 July 2018

Identifiers

DOI

10.1128/AAC.32.11.1738

1 reference

8 August 2017

1 reference

8 August 2017

1 reference